Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Gene Therapy Potency Assay Summit 2024

Evvnt Promotion / evvnt
-
16.07.2024 - 18.07.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:30 PM
 
Temi della conferenza
The 2nd Gene Therapy Potency Summit is returning to Boston in July to support you in designing and validating robust potency assays to accelerate commercialization across a range of vector types and delivery modalities.

Featuring a speaker faculty of over 27 industry-leading experts from key biotech and pharmaceutical companies, this summit offers the most comprehensive agenda to date.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2239928-3?pid=4832

Speakers: Adnan Arnaout Senior Principal Scientist, Prevail Therapeutics, Alec Knapp Scientist, Tune Therapeutics, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2239928-2?pid=4832
Ms. Karina Bikerniece
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference + 2 Workshops - Drug Developers: USD 4397.00, Conference + 2 Workshops - Service Providers: USD 2999.00, Conference Only - Drug Developers: USD 5297.00, Conference Only - Service Providers: USD 3699.00
I partecipanti attesi
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichisches Rotes KreuzSwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für WienÖsterreichische Akademie der ÄrzteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHelix - Forschung & Beratung WienEuropean Public Health Association (EUPHA)